Rabeprazole and Tamiflu drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rabeprazole (rabeprazole sodium) and Tamiflu (oseltamivir phosphate). Common drug interactions include drug ineffective among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Rabeprazole and Tamiflu. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Rabeprazole?

Rabeprazole has active ingredients of rabeprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 31,689 Rabeprazole users. Check the latest studies of Rabeprazole.

What is Tamiflu?

Tamiflu has active ingredients of oseltamivir phosphate. It is often used in the flu. eHealthMe is studying from 22,209 Tamiflu users. Check the latest studies of Tamiflu.

On Jul, 26, 2026

44 people who take Rabeprazole and Tamiflu together, and have interactions are studied.

Rabeprazole and Tamiflu drug interactions.

What are the common drug interactions of Rabeprazole and Tamiflu, by gender? *:

female:

Drug ineffective
Headache (pain in head)
Acute respiratory distress syndrome
Colitis ulcerative (inflammation of colon with ulcer)
Pathogen resistance
Respiratory failure (inadequate gas exchange by the respiratory system)
Weight decreased
Abdominal pain upper
Agitation (state of anxiety or nervous excitement)
Anaemia (lack of blood)

male:

Fall
Back pain
Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
Neck injury
Gastric dysplasia (stomach with abnormality of development)
Malaise (a feeling of general discomfort or uneasiness)
Pneumonia
Asthma
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)

What are the common drug interactions of Rabeprazole and Tamiflu, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Abdominal pain upper
Blood pressure increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Double stranded dna antibody positive
Drug ineffective
Headache (pain in head)
Immunosuppressant drug level increased
Iron deficiency anaemia
Pharyngitis (inflammation of the pharynx, causing a sore throat)
Renal impairment (severely reduced kidney function)

30-39:

Pericarditis (inflammation of the pericardium)

40-49:

Agitation (state of anxiety or nervous excitement)
Anger
Arthralgia (joint pain)
Back pain
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Bronchitis acute (acute inflammation of the mucous membrane in the bronchial tubes)
Constipation
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Febrile neutropenia (fever with reduced white blood cells)
Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)

50-59:

Faeces discoloured
Fall
Gastric cancer (stomach cancer)
Gastric dysplasia (stomach with abnormality of development)
Loss of consciousness
Nausea (feeling of having an urge to vomit)

60+:

Fall
Back injury
Neck pain
Pain in extremity
Drug ineffective
Respiratory failure (inadequate gas exchange by the respiratory system)
Malaise (a feeling of general discomfort or uneasiness)
Overdose
Pneumonia
Acute respiratory distress syndrome

What are the existing conditions these people have? *

Asthma: 17 people, 38.64%
Sleep Disorder: 3 people, 6.82%
High Blood Pressure: 3 people, 6.82%
Gastric Ulcer (stomach ulcer): 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Rabeprazole and Tamiflu?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously